Abstract
Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children. Genetics and inflammatory elements seem to act as major underlying factors in its pathogenesis. The aim of this study is to identify the associations between interleukin-6 (IL-6) gene polymorphisms and individuals’ vulnerability to JIA in a group of Iranian pediatric patients. Fifty-four patients with JIA were enrolled in this investigation and compared with 139 healthy individuals. Using polymerase chain reaction with sequence-specific primers, cytokine genotyping was performed. The allele and genotype frequencies of two single nucleotide polymorphisms (SNPs) within the IL-6 gene at −174 and +565 positions were assessed. A significant positive association was observed for IL -6 −174 G allele in the patient group (p = 0.02). Furthermore, a positive association was observed in patients with JIA for the GG genotype at the same position (p < 0.01), thus revealing a predisposing effect in JIA patients. On the other hand, a significant negative association was found for IL-6 −174 CG genotype (p < 0.01) in the case group. No significant difference was discovered in both the allelic and genotypic frequencies of IL-6 +565 position between patients and controls. Additionally, haplotype analysis divulged over representation of IL-6 GG haplotype in patient group (p < 0.01) as well as IL-6 CG haplotype in healthy controls (p < 0.01). Certain allele, genotype, and haplotype in IL-6 gene were over expressed in patients with JIA, which probably could render individuals more susceptible to this disease.
Similar content being viewed by others
References
Prakken B, Albani S, Martini A (2011) Juvenile idiopathic arthritis. Lancet 377:2138–2149
Oen K (2000) Comparative epidemiology of the rheumatic diseases in children. Curr Opin Rheumatol 12:410–414
Berkun Y, Padeh S (2010) Environmental factors and the geoepidemiology of juvenile idiopathic arthritis. Autoimmun Rev 9:A319–A324
Singh S, Bhattad S, Danda D (2014) Genetics of juvenile idiopathic arthritis. Int J Rheum Dis 17:233–236
Dimopoulou DG, Zervou MI, Trachana M, et al. (2013) Investigation of juvenile idiopathic arthritis susceptibility loci: results from a Greek population. Hum Immunol 74:1194–1198
Hollegaard MV, Bidwell JL (2006) Cytokine gene polymorphism in human disease: on-line databases, supplement 3. Genes Immun 7:269–276
Tahghighi F, Ziaee V, Moradinejad MH, et al. (2015) Tumor necrosis factor-alpha single nucleotide polymorphisms in juvenile systemic lupus erythematosus. Hum Immunol 76:533–536
Mahmoudi M, Tahghighi F, Ziaee V, et al. (2014) Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus. Int J Immunogenet 41:512–517
Rezaei A, Ziaee V, Sharabian FT, et al. (2015) Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus. Clin Rheumatol 34:1059–1064
Ziaee V, Tahghighi F, Moradinejad MH, et al. (2014) Interleukin-6, interleukin-1 gene cluster and interleukin-1 receptor polymorphisms in Iranian patients with juvenile systemic lupus erythematosus. Eur Cytokine Netw 25:35–40
Maddah M, Harsini S, Rezaei A, et al. (2016) Association of interleukin-2, but not interferon-gamma, single nucleotide polymorphisms with juvenile idiopathic arthritis. Allergol Immunopathol (Madr)
Ziaee V, Rezaei A, Harsini S, et al. (2016) Polymorphisms of genes encoding interleukin-4 and its receptor in Iranian patients with juvenile idiopathic arthritis. Clin Rheumatol
Harsini S, Ziaee V, Tahghighi F, et al. (2016) Association of interleukin-2 and interferon-gamma single nucleotide polymorphisms with juvenile systemic lupus erythematosus. Allergol Immunopathol (Madr)
Harsini S, Ziaee V, Maddah M, et al. (2016) Interleukin 10 and transforming growth factor beta 1 gene polymorphisms in juvenile idiopathic arthritis. Bratisl Lek Listy 117:258–262
Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2012) The association between interleukin-6 polymorphisms and rheumatoid arthritis: a meta-analysis. Inflamm Res 61:665–671
Smolen JS, Beaulieu A, Rubbert-Roth A, et al. (2008) Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet 371:987–997
Petty RE, Southwood TR, Manners P, et al. (2004) International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392
Amirzargar AA, Naroueynejad M, Khosravi F, et al. (2008) Cytokine single nucleotide polymorphisms in Iranian populations. Eur Cytokine Netw 19:104–112
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Robak T, Gladalska A, Stepien H, Robak E (1998) Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis. Mediat Inflamm 7:347–353
Lipsky PE (2006) Interleukin-6 and rheumatic diseases. Arthritis Res Ther 8(Suppl 2):S4
Ogilvie EM, Fife MS, Thompson SD, et al. (2003) The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families. Arthritis Rheum 48:3202–3206
Li F, Xu J, Zheng J, et al. (2014) Association between interleukin-6 gene polymorphisms and rheumatoid arthritis in Chinese Han population: a case-control study and a meta-analysis. Sci Rep 4:5714
Arman A, Coker A, Sarioz O, Inanc N, Direskeneli H (2012) Lack of association between IL-6 gene polymorphisms and rheumatoid arthritis in Turkish population. Rheumatol Int 32:2199–2201
Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, et al. (2009) Interleukin-6 gene -174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis. Clin Exp Rheumatol 27:964–970
Ceccarelli F, Perricone C, Fabris M, et al. (2011) Transforming growth factor beta 869C/T and interleukin 6-174G/C polymorphisms relate to the severity and progression of bone-erosive damage detected by ultrasound in rheumatoid arthritis. Arthritis Res Ther 13:R111
Jancic I, Arsenovic-Ranin N, Sefik-Bukilica M, et al. (2013) 174G/C interleukin-6 gene promoter polymorphism predicts therapeutic response to etanercept in rheumatoid arthritis. Rheumatol Int 33:1481–1486
Pawlik A, Wrzesniewska J, Florczak M, Gawronska-Szklarz B, Herczynska M (2005) IL-6 promoter polymorphism in patients with rheumatoid arthritis. Scand J Rheumatol 34:109–113
Acknowledgment
This study was funded by Tehran University of Medical Sciences and Health Services (grant number: 91–03–30–18149).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Disclosures
None.
Rights and permissions
About this article
Cite this article
Ziaee, V., Maddah, M., Moradinejad, MH. et al. Association of interleukin-6 single nucleotide polymorphisms with juvenile idiopathic arthritis. Clin Rheumatol 36, 77–81 (2017). https://doi.org/10.1007/s10067-016-3407-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-016-3407-6